Marcelo Neves Lubianca

Marcelo Neves Lubianca

Auto-generated profile, based on publicly available information

Marcelo Neves Lubianca

Pontifical Catholic University of Rio Grande do Sul, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2025 in American Journal of Otolaryngology
Verified
Journal Article
Open access
NCNeemias Santos Carneiro
Neemias Santos Carneiro
JNJosé Faibes Lubianca Neto
José Faibes Lubianca Neto
BSBárbara Salgueiro
Bárbara Salgueiro
RPRita Carolina Pozzer Krumenauer Padoin
Rita Carolina Pozzer Krumenauer Padoin
RDRenata Loss Drummond
Renata Loss Drummond
MLMarcelo Neves Lubianca
Marcelo Neves Lubianca
Percutaneous vocal fold lateralization (PVFL) consists of external fixation with non-absorbable percutaneous suture of the vocal fold in a lateral position, under direct glottic visualization. The objective, through a systematic review, was to identify, select, evaluate, and synthesize the relevant evidence available to define whether PVFL is effective in avoiding the tracheostomy, as well as whether it is effective in allowing decannulation of children who have already been tracheostomized. Secondarily, vocal quality, complications and reversibility of the procedure were evaluated. A systematic review was carried out based on the protocols described in the QUORUM/PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines. The search strategy was carried out in the PubMed, Embase, Scopus, Web of Science, SciELO and VHL databases. The terms searched were a combination of indexed keywords using Boolean terms. Primary studies that documented intervention outcomes in patients with BVFP; Studies including pediatric patients (defined here as <18 years of age); and studies with well documented postoperative follow-up. Duplicate studies or with the same clinical data; articles that exclusively evaluated other surgical interventions, animal studies, reviews, or post-mortem studies; and studies with only patients with unilateral vocal fold paralysis. Among the patients under study, 80 cases, underwent the surgical technique under study, 41 of these (51.25 %) are male. The average age of patients undergoing the procedures ranged from 4 days to 10 years of age. Most patients already had preoperative comorbidities, generally cardiothoracic and laryngeal, followed by neurological causes. In 31 % of patients, only a high-flow nasal catheter was required and in 3 patients, transient orotracheal intubation was required. At the mean follow-up of 30 months [SD:24], around 20 of the 80 (25.6 %) patients presented some degree of dysphonia. However, there was no standardization of scales. Approximately 11 % of patients had some postoperative complication, with reintubation due to glottic edema being the most prevalent. There was only 1 death. Preoperatively, 38 % of patients with BVFP were tracheostomized. After the procedure, only 13 % of them still needed to continue with the tracheostomy during the postoperative period. However, 13 % of patients needed to remain with a tracheostomy. Among the tracheostomy patients, only 3 of them achieved return of vocal fold mobility. Among all patients, vocal fold mobility returned in 35 % of patients, with a total of 10 % of patients postoperatively. However, there were studies that did not report mobility due to the short follow-up. During follow-up, 6 patients required revision procedures to relocate lateralization suture or even due to skin abscess. Granuloma occurred in only 1 case. There was just one study reporting suture removal in 3 of its cases. PVFL is an effective and safe procedure, either due to its high rates of avoiding tracheostomy and allowing decannulation, in addition to the potential for reversibility, or due to its low invasiveness, and can be used to treat PBPV in newborns and infants. However, more controlled studies are needed with longer follow-up of patients, with objective outcomes in the assessment of dysphonia and swallowing, in addition to assessing the incidence of long-term complications. Randomized, multicenter clinical trials are welcome to allow for a larger sample, comparing the efficacy and adverse effects of PVFL in relation to tracheostomy and other existing endoscopic procedures.

13 July 2024 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
BSBárbara Duarte Salgueiro
Bárbara Duarte Salgueiro
NCNeemias Santos Carneiro
Neemias Santos Carneiro
HNHemiliy Izabel Alves Neves
Hemiliy Izabel Alves Neves
ICIsabel Saorin Conte
Isabel Saorin Conte
RPRita Carolina Pozzer Krumenauer Padoin
Rita Carolina Pozzer Krumenauer Padoin
JNJosé Faibes Lubianca Neto
José Faibes Lubianca Neto
Percutaneous Vocal Fold Lateralization (PVFL) consists of external fixation with non-absorbable percutaneous suture of the vocal fold in a lateral position, under direct glottic visualization. The objective of this study is to determine the effectiveness of PVFL in a university pediatric hospital, as well as to describe the potential risks and complications of the surgery. Retrospective cohort study, with data collected from electronic medical records. The study was approved by the Research Ethics Committee of the institution. Surgeries were performed with the modified Lichentenberg technique and data, and outcomes were analyzed. Six patients with Bilateral Vocal Fold Paralysis who underwent Percutaneous Vocal Fold Lateralization were evaluated. Three patients were male. The age at diagnosis ranged from 2 to 132 days (mean 10.5 days). The reason for investigating the upper airway was the presence of increased work of breathing and stridor. Five patients had a favorable clinical evolution, with spontaneous ventilation in room air and absence of stridor or ventilatory effort, without the need for tracheostomy. Surgical results in this series corroborate the findings of other similar cohorts, which showed Percutaneous Vocal Fold Lateralization as a safe and effective procedure in avoiding tracheostomy or allowing decannulation in children with Bilateral Vocal Fold Paralysis. PVFL seems to be a safe and effective procedure, but it has morbidity, due to immediate, and probably late, non-serious complications. Studies with a larger number of patients, with longer follow-up and using a controlled and randomized clinical design are needed to establish the role of PVFL in the treatment of BVFP in newborns and infants. Level 4 (step 4).

10 August 2026 in BMC Urology
Verified
Journal Article
Open access
PDF file
NFNilson Marquardt Filho
Nilson Marquardt Filho
Ana Paula Beck da Silva EtgesAna Paula Beck da Silva Etges
Ana Paula Beck da Silva Etges
MMMiriam Allein Zago Marcolino
Miriam Allein Zago Marcolino
PRPedro Henrique Polanczyk Rohde
Pedro Henrique Polanczyk Rohde
ICIsabela Carvalhal
Isabela Carvalhal
GCGustavo Franco Carvalhal
Gustavo Franco Carvalhal
Postoperative complications are critical indicators of surgical quality and safety. Evaluating these outcomes in teaching hospitals is essential for both c

1 July 2026 in International Archives of Otorhinolaryngology
Verified
Journal Article
Open access
MSMaira I. S. Stangler
Maira I. S. Stangler
JNJosé F. Lubianca Neto
José F. Lubianca Neto
MLMarcelo N. Lubianca
Marcelo N. Lubianca
Dipyrone is one of the most commonly used postoperative analgesics. However, there are only two randomized, placebo-controlled clinical trials evaluating its effect in pediatric tonsillectomies. To compare postoperative pain outcomes following the use of pre-incisional dipyrone or placebo in pediatric adenotonsillectomy. This was a randomized, double-blind, parallel, placebo-controlled clinical trial in children aged 4 to 14 years who underwent adenotonsillectomy. A total of 76 participants were randomized into the intervention/dipyrone group (n = 39) and the placebo group (n = 37). All received either dipyrone or saline solution (placebo) at one of two time points: before the surgical incision or at the end of surgery. The mean age was 6.8 years and weight was 32.1 kg. In the intervention group, vital signs were normal and only 7.7% experienced emesis, compared with 8.1% in the placebo group. Food intake was anticipated by 1,1 hours in the dipyrone group. Pain was controlled in at least 77.6% of participants at all evaluated time points (H0, H1, H3, and H6) in both groups. At H3, pain was controlled in 54.2% of the intervention group compared with 45.8% in the placebo group. In addition, the dipyrone group demonstrated a tendency toward a lower need for opioids in H1 and H3, reducing opioid administration by 50% and 52.63%, respectively, compared with placebo. A trend toward pain relief, earlier diet acceptance, and a lower need for opioids was observed in the group that received preemptive dipyrone. The results did not reach statistical significance, likely due to a type II error.